Is Sai Life Sciences Ltd. a good investment? Sai Life Sciences Ltd. (SAILIFE.NS) is currently trading at 1333.40 INR. Market analysts have a consensus price target of 1275.00 INR. This suggests the asset is currently trading above analyst expectations.
In terms of valuation, the stock trades at a P/E ratio of 80.77. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Sai Life Sciences Ltd. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 24.55.
No, it does not currently pay a dividend.
Sai Life Sciences Ltd. is classified as a Stock.
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 16.45.
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Community Discussion